Biopharma News : Biopharma and Pharma news from all around the world :
- Industry collab: Oregon Bio and Onward Eugene announce development partnership to grow jobs and biotech in the Willamette Valley
- Aditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants
- Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021
- Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection
- Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
- Boston Properties Announces Full-Building Lease With Leading Biotech Firm at 751 Gateway in South San Francisco
- Gyroscope Therapeutics Announces Appointment of Tony Adamis to Board of Directors
- MEI Pharma Announces Closing of Public Offering of Common Stock
- Taysha Gene Therapies Announces Late-Breaking Abstract and Poster Presentation on Positive Preclinical Data For TSHA-105 Demonstrating Therapeutic Potential for the Treatment of Epilepsy Caused by SLCA13A5 Deficiency
- MedX Health to Present at the SNN Network Canada Virtual Event December 7 – 9, 2021
- Global Mammography Equipment Industry to 2027 – Alternative Breast Imaging Technologies are Strong Contenders for Mammography – ResearchAndMarkets.com
- TransPerfect Life Sciences Acquires LMK Clinical Research Consulting
- Global ePharmacy Markets Report 2022-2026 – ResearchAndMarkets.com
- Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Research Report 2022-2026 – ResearchAndMarkets.com
- TNF Alpha Inhibitors Global Markets Research Report 2021: Focus on Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), & Simponi (golimumab) – ResearchAndMarkets.com
- Dr. Lindee Goh of Tapestry Networks and Jeffrey Feike, President and Chief Administrative Officer of Fort Loudoun Medical Center, Join Tevogen Bio’s Innovation and Public Health Advisory Council
- bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
- Global Alzheimer Diagnostic Tests Pipeline Product Landscape Market Report 2021 – ResearchAndMarkets.com
- IncellDx Appoints Todd Pollard as Chief Operating Officer
- Global Thyroid Function Tests Devices Pipeline Product Market Landscape Report 2021 – ResearchAndMarkets.com
- Global Auto-Immune Diseases Diagnostic Tests Pipeline Landscape Market Report 2021 – ResearchAndMarkets.com
- Carter’s Ortega Pharmacy Owner Found Not Guilty of All Charges in United States District Court, Middle District of Florida
- Recuro Health Hosts Free Webinar on Preparing for COVID-19 Mandates, Featuring Essential Tools to Help Employers Ensure a Safe and Healthy Workplace
- New Labour Market Report Indicates Western Canada’s Bio-Economy Growing, but Lacks Workers
- Global RNA Delivery Technology Vendors Benchmark Report 2021 – ResearchAndMarkets.com
- BostonGene Announces Three Oral and Four Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
- Guardian Pharmacy Services and Southern Pharmacy Services Strengthen N.C. Footprint with Acquisition
- Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
- ESCAPE Bio Appoints Mark Kaufmann as Chief Financial Officer and Chief Business Officer
- Yarrow Biotechnology Appoints Dr. Mark T. Keating as Chief Scientific Officer
Biotech – Biopharma News!
- Original-Research: Defence Therapeutics Inc. (von GBC AG)
- XPhyto Therapeutics Corp.: XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
- Straumann Group Capital Markets Day 2021
- Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option
- COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.
- COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.
- M1 Kliniken AG continues successful development in Q4 2021
- Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital
- Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH)
- Adrenomed Receives Positive EMA Scientific Advice for Further Clinical Development of Adrecizumab in Septic Shock
- MPH Health Care AG: result Q3-2021
- Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
- Change in Newron Board of Directors
- Change in Newron Board of Directors
- SynBiotic SE: Most important cannabis merger in Europe
- Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company’s new operating model
- Xlife Sciences AG appoints new Chief Financial Officer
- PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen
- SynBiotic SE: Majority takeover of hemp industry pioneer Daniel Kruse’s group of companies as part of a capital increase in kind
- Abivax’s phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
- Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
- DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT
- Evolva announces private placement of 63.8m shares to VERAISON raising gross proceeds of CHF 7.5m and CFO departure
- Relief Therapeutics Announces Executive Changes
- Biotest AG: Biotest receives approval for Intratect(R) in France
- Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir
- MorphoSys AG: Corporate Calendar 2022
- eHealth-Tec achieves first place in the TOP 100 competition
- IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05
- Adjustment of conversion price of convertible bond 2020/2023 (ISIN DE000A3E46M4) to EUR 1.61 after implemented capital increase
- First Emotionally Intelligent Robot Makes Visiting the Dentist Fun for Kids
- TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference
- Bavarian Nordic A/S Announces Completion of Directed Issue of 6,373,680 New Ordinary Shares
- vTv Therapeutics Announces Restructuring to Prioritize its Lead Program and Focus Operations
- Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement
- Y-mAbs Hosting Virtual Research and Development Day
- IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting
- Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board
- HealthEquity Reports Third Quarter Ended October 31, 2021 Financial Results
- Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV
- Roche completed the repurchase of Roche shares from Novartis
- Bavarian Nordic A/S Launches Offering of up to 6,373,680 New Shares in a Directed Issue
- Sky Wellness Premium CBD Collection Now Available at Multiple Online Marketplaces Including CBD.co and Hemper
- Syapse Announces New Studies Published at Virtual ISPOR Europe 2021
- BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
- Pulmocide Receives Investment from the Cystic Fibrosis Foundation
- AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
- Rhythm Pharmaceuticals and RareStone Ltd. Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China
- OPKO Health Announces the Passing of Director Dr. Richard Lerner
- Calibre Scientific Acquires Benson Polymeric, a Manufacturer of Polymer-Based High-Performance Liquid Chromatography (HPLC) Columns and Resin
- Valneva SE: declaration of shares and voting rights – November 2021
- Aino Health AB (publ): Aino Health signs partner agreement with Pihlajalinna Plc
- OKYO Pharma Limited (“OKYO” or the “Company”) to File IND in Q3 2022 for OK-101 to treat Dry Eye Disease (“DED”) and to go directly to a Phase 2 Human Clinical Efficacy Trial in DED Patients with a planned start date in Q4 2022 on an accelerated basis
- Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base
- HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
- Rexlemestrocel-L Shows Greatest Treatment Benefit on Major Adverse Cardiovascular Events in High-Risk Heart Failure Patients With Diabetes and/or Myocardial Ischemia
- Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12
- Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron
- Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News